Financhill
Back

Halozyme Therapeutics Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
77

HALO
Halozyme Therapeutics

Last Price:
$59.15
Seasonality Move:
4.09%
Sell
37

DRUG
Bright Minds Biosciences

Last Price:
$37.50
Seasonality Move:
-32.13%
Buy
77
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $59.14. The Score for HALO is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $37.39. The Score for DRUG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $59.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $37.39
    The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.09 Buy
Relative Strength Index (14 RSI): 67.34 Buy
Chaikin Money Flow: 1203801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.3 - 58.2) Buy
Bollinger Bands (100): (48.31 - 57.53) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 49.78 Sell
Chaikin Money Flow: 27952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.12 - 42.26) Buy
Bollinger Bands (100): (24.86 - 48.56) Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.95 Buy
20-day SMA: 57.6 Buy
50-day SMA: 53.83 Buy
200-day SMA: 53.38 Buy
8-day EMA: 58.08 Buy
20-day EMA: 57.29 Buy
50-day EMA: 55.23 Buy
200-day EMA: 51.85 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.75 Buy
20-day SMA: 38.76 Sell
50-day SMA: 37.71 Sell
200-day SMA: 18.92 Buy
8-day EMA: 36.45 Buy
20-day EMA: 37.51 Sell
50-day EMA: 37.11 Buy
200-day EMA: 24.13 Buy

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.01 per share, an increase this year of $0.80 per share, and an increase next year of $1.52 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):